The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study

BACKGROUND: The prognosis of recurrent or refractory advanced childhood solid tumor patients is very poor and new therapeutic strategies are in urgent need. This study aimed to determine the efficacy and safety of apatinib in pediatric refractory/relapse advanced solid tumor patients. PATIENTS AND M...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Manag Res
Glavni autori: Sun, Feifei, Lu, Suying, Zhen, Zijun, Zhu, Jia, Wang, Juan, Huang, Junting, Zhang, Yu, Li, Hui, Cai, Ruiqing, Liu, Meiling, Wu, Liuhong, Sun, Xiaofei, Zhang, Yizhuo
Format: Artigo
Jezik:Inglês
Izdano: Dove 2020
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7383017/
https://ncbi.nlm.nih.gov/pubmed/32801866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S258689
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items